Goldman Sachs’s LifeMD LFMD Stock Holding History
Bought
Maintained
Sold
Other funds holding LFMD
PGCM
BRF
RA
Goldman Sachs's LFMD Position: Q2 2026 in Review
Goldman Sachs reduced its LifeMD (LFMD) stake by 78% in Q2 2026, selling an estimated $1.59M and leaving 99,618 shares worth $411K. The position accounts for ﹤0.01% of the portfolio, ranked #5821.
Goldman Sachs first reported a position in LFMD in Q1 2021 and has held it in 15 quarters since. The position peaked at $3.85M in Q1 2024. 115 funds tracked by Wall St. Rank hold LFMD as of Q2 2026.
- Goldman Sachs held 99,618 shares of LifeMD worth $411K as of Q2 2026.
- Goldman Sachs sold 360,185 LifeMD shares in Q2 2026, an estimated $1.59M.
- LifeMD made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #5821 holding.
- Goldman Sachs first reported a position in LifeMD in Q1 2021 and has held it in 15 quarters since.
- Goldman Sachs's LifeMD position peaked at $3.85M in Q1 2024.
- 115 funds tracked by Wall St. Rank held LifeMD as of Q2 2026.
Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.